期刊
ENDOCRINE PRACTICE
卷 22, 期 -, 页码 1-42出版社
AMER ASSOC CLINICAL ENDOCRINOLOGISTS
DOI: 10.4158/EP161435.GL
关键词
-
资金
- Amgen Inc
- NPS Pharmaceuticals
- NASA-JSC
- Amgen
- Merck
- Eli Lilly and Company
- Opko Health
- Novartis
- GE Healthcare Lunar
- Amgen Inc.
- NPS Pharmaceuticals, Inc.
- Gilead Sciences
- Radius Health
- AgNovos
- Radius Pharma
- Roche
- Ultragenyx
- Allergan Pharmaceuticals
- GrA1/4nenthal Group
- Alexion
- Boehringer Ingelheim
- Immunodiagnostics
- Merck Serrano
- National Bone Health Alliance
- Roche Diagnostics
- Regeneron
- Daiichi Sankyo
- Elsevier
- Cystic Fibrosis Foundation
- NIH
- Abbvie
- Sanofi
- Sprout
- Metrowest Medical Center
- Beth Israel Deaconess Medical Center, Needham
- Beth Israel Deaconess Medical Center, Boston
- Boston University Dental School and Medical School
- Celgene Corporation
- MCE Conferences
- Boston University
- Advance Medical, Inc.
The American Association of Clinical Endocrinologists/American College of Endocrinology Medical Guidelines for Practice are systematically developed statements to assist healthcare professionals in medical decision-making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据